LON:SALV - SalvaRx Group Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SalvaRx Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 4.50 0.00 (0.00 %) (As of 01/9/2020) Add Compare Today's Range 4.50Now: GBX 4.50▼ 4.5050-Day Range 4.50MA: GBX 4.50▼ 4.5052-Week Range 4.50Now: GBX 4.50▼ 15.40VolumeN/AAverage Volume49,570 shsMarket Capitalization£1.65 millionP/E Ratio0.03Dividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man. Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:SALV Previous SymbolLON:3LEG CUSIPN/A CIKN/A Webhttp://www.salvarx.io/ Phone+44-1624-811611Debt Debt-to-Equity Ratio14.50 Current Ratio1.89 Quick Ratio1.89Price-To-Earnings Trailing P/E Ratio0.03 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£64.50 million Price / Sales0.03 Cash FlowGBX 1.29 per share Price / Cash Flow3.50 Book ValueGBX 15.40 per share Price / Book0.29Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees2 Outstanding Shares36,700,000Market Cap£1.65 million Next Earnings DateN/A OptionableNot Optionable Receive SALV News and Ratings via Email Sign-up to receive the latest news and ratings for SALV and its competitors with MarketBeat's FREE daily newsletter. LSE:SALV Rates by TradingView SalvaRx Group (LON:SALV) Frequently Asked Questions What is SalvaRx Group's stock symbol? SalvaRx Group trades on the London Stock Exchange (LON) under the ticker symbol "SALV." Has SalvaRx Group been receiving favorable news coverage? News headlines about SALV stock have trended negative on Saturday, InfoTrie reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SalvaRx Group earned a news impact score of -2.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an effect on the stock's share price in the near term. View News Stories for SalvaRx Group. Who are some of SalvaRx Group's key competitors? Some companies that are related to SalvaRx Group include Nanollose (NC6), Biopharmx (BPMX), Innovotech (IOT), Fiji Kava (FIJ), Amplia Therapeutics (ATX), Factor Therapeutics (FTT), IBEX Technologies (IBT), Revive Therapeutics (RVV), Hemispherx BioPharma (HEB), Hemostemix (HEM), Netscientific (NSCI), BPH Energy (BPH), Physiomics (PYC), CAN-FITE BIOPHA/S (CANF) and Can-Fite Biopharma (CANF). What other stocks do shareholders of SalvaRx Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other SalvaRx Group investors own include Premier African Minerals (PREM), Cradle Arc (CRA), Cora Gold (CORA), Big Sofa Technologies Group (BST), Bahamas Petroleum (BPC), Braemar Shipping Services (BMS), Bacanora Lithium (BCN), Angus Energy (ANGS), Allergy Therapeutics (AGY) and Afren (AFR). Who are SalvaRx Group's key executives? SalvaRx Group's management team includes the folowing people: Mr. Denham Hervey Newall Eke, CFO & Director (Age 67) How do I buy shares of SalvaRx Group? Shares of SALV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is SalvaRx Group's stock price today? One share of SALV stock can currently be purchased for approximately GBX 4.50. How big of a company is SalvaRx Group? SalvaRx Group has a market capitalization of £1.65 million and generates £64.50 million in revenue each year. SalvaRx Group employs 2 workers across the globe.View Additional Information About SalvaRx Group. What is SalvaRx Group's official website? The official website for SalvaRx Group is http://www.salvarx.io/. How can I contact SalvaRx Group? SalvaRx Group's mailing address is Commerce House, 1 Bowring Road, RAMSEY, RAMSAY, IM8 2LQ, Isle of Man. The company can be reached via phone at +44-1624-811611. MarketBeat Community Rating for SalvaRx Group (LON SALV)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 138 (Vote Outperform)Underperform Votes: 110 (Vote Underperform)Total Votes: 248MarketBeat's community ratings are surveys of what our community members think about SalvaRx Group and other stocks. Vote "Outperform" if you believe SALV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SALV will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2020 by MarketBeat.com StaffFeatured Article: Why does a company issue an IPO?
